Search

Author/Creator Issa, Maher

11. Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials. Issue 1 (2nd January 2020)

Authors:
Harigai, Masayoshi; Takeuchi, Tsutomu; Smolen, Josef S.; Winthrop, Kevin L.; Nishikawa, Atsushi; Rooney, Terence P.; Saifan, Chadi G.; Issa, Maher; Isaka, Yoshitaka; Akashi, Naotsugu; Ishii, Taeko; Tanaka, Yoshiya
Journal:
Modern rheumatology
Issue:
Volume 30:Issue 1(2020)
Page Start:
36
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. THU0078 SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 7 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS. (June 2019)

Authors:
Genovese, Mark C.; Smolen, Josef S.; Takeuchi, Tsutomu; Burmester, Gerd Rüdiger; Brinker, Dennis; Rooney, Terence; Zhong, Jinglin; Mo, Daojun; Saifan, Chadi; Cardoso, Anabela; Issa, Maher; Wu, Wen-Shuo; Winthrop, Kevin
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗